Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Revolution Medicines Inc. Common Stock (RVMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Revolution Medicines Inc. Common Stock — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Revolution Medicines Inc. Common Stock trades at $189.32 (market cap $40.32B). The key difference: Revolution Medicines Inc. Common Stock is far larger — about 3.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Revolution Medicines Inc. Common Stock is more actively traded (4,855,734 versus 2,179,278). Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Revolution Medicines Inc. Common Stock for 0 Days on average.
| HALO | RVMD | |
|---|---|---|
Market Cap | $12.58B | $40.32B |
Volume | 2,179,278 | 4,855,734 |
Sector | Health | Health |
52-Week High | $115.22 | $221.15 |
52-Week Low | $61.63 | $47.50 |
Typical Hold Time | 1 Days | 0 Days |
Enterprise Value | $14.49B | $37.02B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Revolution Medicines Inc. Common Stock
Revolution Medicines develops precision medicines for cancer. Its programs focus on targeting RAS-driven cancers and related signaling pathways.
Read more on RVMD →
